Expand ACXP Menu
ACXP MENU

ACXP Stock Posts


ACXP #AcurxPharmaceuticals stock declines -18.2% in premarket,

Premarket Decliner

ACXP Acurx Pharmaceuticals5.01-1.02-16.9%

Premarket:4.10-0.91 (-18.2%)

Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

PRNewswireFri, 13-Mar 7:01 AM
Unusual Option Volume

ACXP Acurx Pharmaceuticals0.75+0.44 (+144.3%)

Acurx Pharmaceuticals trades 3,456 contracts. News: Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
View Details...
ACXP #AcurxPharmaceuticals stock declines -18.3% in premarket,

Premarket Decliner

ACXP Acurx Pharmaceuticals4.75+0.12+2.6%

Premarket:3.88-0.87 (-18.3%)

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PRNewswireWed, 17-Jan 7:01 AM
Unusual Option Volume

ACXP Acurx Pharmaceuticals3.26-0.53 (-13.9%)

Acurx Pharmaceuticals trades 2,658 contracts.
View Details...
Unusual Option Volume

ACXP Acurx Pharmaceuticals3.61-1.46 (-28.8%)

Acurx Pharmaceuticals trades 2,527 contracts.
View Details...
Unusual Option Volume

ACXP Acurx Pharmaceuticals4.85+0.77 (+18.9%)

Acurx Pharmaceuticals trades 2,157 contracts.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes